International Stem Cell CORP
ISCO- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001355790
In the last 90 days, International Stem Cell CORP insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding International Stem Cell CORP changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 20 | 0 | −20 (−100.0%) |
| Value | $4 | $0 | −$4 (−100.0%) |
New holders (0)
Institutions that held International Stem Cell CORP at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (1)
Institutions that held International Stem Cell CORP at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Accel Wealth Management | 20 | $4 |